Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes. (2017)
Attributed to:
Mitochondrial oxidative damage and human diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-15589-x
PubMed Identifier: 29123192
Publication URI: http://europepmc.org/abstract/MED/29123192
Type: Journal Article/Review
Volume: 7
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322